You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 22, 2025

Drug Price Trends for COUGH DM ER


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for COUGH DM ER

Average Pharmacy Cost for COUGH DM ER

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
COUGH DM ER 30 MG/5 ML SUSP 70000-0187-01 0.06493 ML 2025-03-19
COUGH DM ER 30 MG/5 ML SUSP 46122-0141-21 0.06493 ML 2025-03-19
COUGH DM ER 30 MG/5 ML SUSP 46122-0141-25 0.04785 ML 2025-03-19
COUGH DM ER 30 MG/5 ML SUSP 70000-0302-01 0.06493 ML 2025-03-19
COUGH DM ER 30 MG/5 ML SUSP 00904-6312-56 0.06493 ML 2025-03-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Cough DM ER

Introduction to Cough DM ER

Cough DM ER, a formulation that typically includes dextromethorphan, is a common over-the-counter (OTC) medication used to suppress coughs. Here’s a comprehensive analysis of the market trends, drivers, and price projections for this drug.

Market Size and Growth

The global market for cough suppressant drugs, which includes Cough DM ER, is experiencing steady growth. Here are some key statistics:

  • The global dextromethorphan market, a significant component of the cough suppressant market, was valued at USD 487.25 million in 2022 and is projected to grow at a CAGR of 4.8% from 2023 to 2030, reaching USD 587.31 million by 2030[1].
  • The cough syrup market, which also includes formulations like Cough DM ER, was valued at USD 5.31 billion in 2023 and is expected to grow at a CAGR of 4.2% from 2024 to 2030, reaching nearly USD 7.08 billion[3].

Drivers of Market Growth

Several factors are driving the growth of the market for Cough DM ER:

Increasing Prevalence of Respiratory Conditions

The rising prevalence of respiratory conditions such as the common cold, flu, bronchitis, and chronic respiratory diseases (CRDs) like COPD and asthma is a significant driver. CRDs were the third leading cause of global mortality in 2022, with over 4 million deaths, highlighting the need for effective cough suppressants[3].

Growing Consumer Awareness and Self-Medication

Increased access to healthcare information and the practice of self-medication have led consumers to seek OTC medications like Cough DM ER more frequently. This trend is fueled by the convenience, lower cost, and perceived effectiveness of OTC remedies[1].

Technological Advancements in Drug Delivery Systems

Innovations in drug delivery systems, such as extended-release formulations and combination products, have enhanced the efficacy and convenience of cough medications. These advancements attract consumers and contribute to market expansion[1].

Market Segmentation

The market for Cough DM ER can be segmented in several ways:

Product Type

  • Over-the-counter (OTC) products dominate the market due to high demand and ease of access[1].

Dosage Form

  • Syrups, tablets, and other forms are available, with syrups being a popular choice for both pediatric and adult populations[1].

Distribution Channel

  • Products are sold through various channels including hospital pharmacies, retail pharmacies, and online pharmacies. Online sales are increasingly popular due to convenience and accessibility[1].

Regional Market Analysis

North America

  • North America is expected to hold a dominant position in the cough suppressant market, driven by frequent FDA approvals of new drugs. For instance, the approval of Tuzistra XR in 2015 highlighted the region's favorable regulatory environment[4].

United States

  • The Cold & Cough Remedies market in the United States is projected to grow by 4.54% from 2024 to 2029, reaching a market volume of US$13.97 billion in 2029. Consumers in the U.S. prefer OTC remedies due to their convenience and lower cost compared to prescription medications[2].

Price Projections

Current Pricing

  • Generic versions of Cough DM ER, such as Delsym, are available at discounted prices. For example, generic Delsym (cough DM ER) 30mg/5ml can start at $0.12 per dose, offering significant savings for consumers[5].

Future Pricing Trends

  • Given the steady growth in demand and advancements in drug delivery systems, prices are likely to remain competitive. However, any significant technological advancements or changes in regulatory frameworks could impact pricing. The overall trend suggests stable to slightly increasing prices due to inflation and market demand[1][3].

Challenges and Restraints

Rising Competition

  • The market faces rising competition from various brands and generic versions, which can impact pricing and market share. Companies must innovate and differentiate their products to maintain market position[1].

Regulatory Frameworks

  • Changes in regulatory policies or stricter guidelines can affect the production and distribution of Cough DM ER, potentially influencing prices and availability[1].

Key Takeaways

  • The global market for cough suppressant drugs, including Cough DM ER, is growing steadily driven by increasing respiratory conditions and consumer awareness.
  • Technological advancements and favorable regulatory environments in regions like North America support market growth.
  • Pricing is expected to remain competitive, with generic options offering significant savings for consumers.
  • Rising competition and regulatory changes are key challenges that companies need to address.

FAQs

What is the expected growth rate of the global dextromethorphan market?

The global dextromethorphan market is projected to grow at a CAGR of 4.8% from 2023 to 2030[1].

Which region dominates the cough suppressant market?

North America is expected to hold a dominant position in the cough suppressant market due to frequent FDA approvals of new drugs[4].

What are the main drivers of the market growth for Cough DM ER?

The main drivers include the increasing prevalence of respiratory conditions, growing consumer awareness and self-medication practices, and technological advancements in drug delivery systems[1][3].

How does the pricing of generic Cough DM ER compare to branded versions?

Generic versions of Cough DM ER, such as Delsym, are significantly cheaper, starting at $0.12 per dose, offering substantial savings for consumers[5].

What are the challenges faced by the Cough DM ER market?

The market faces challenges such as rising competition from various brands and generic versions, and potential changes in regulatory frameworks[1].

Sources

  1. Data Bridge Market Research: Global Dextromethorphan Market – Industry Trends and Forecast to 2030.
  2. Statista: Cold & Cough Remedies - US | Statista Market Forecast.
  3. Maximize Market Research: Cough Syrup Market - Industry Analysis and Forecast (2024-2030).
  4. Coherent Market Insights: Cough Suppressant Drugs Market - Price, Size, Share & Growth.
  5. PharmacyChecker.com: Cough Dm Er Prices - U.S. & International.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.